Slug is an essential target of TGFbeta2 signaling in the developing chicken heart.
An epithelial-mesenchymal cell transformation (EMT) occurs during the development of endocardial cushions in the atrioventricular (AV) canal of the heart. This is a complex developmental process regulated by multiple extracellular signals and signal transduction pathways. It was recently shown that the transcription factor Slug is expressed in the AV canal and is required for initial steps of EMT. Treatment of AV canal explants with either antisense oligodeoxynucleotides toward Slug or anti-TGFbeta2 antibody inhibited initial steps of EMT. Others have identified roles for HGF and BMP during EMT in the heart. Both HGF and BMP are known to regulate Slug in other cell types. To determine whether TGFbeta2 or other signaling factors regulate Slug expression during EMT in the heart, we cultured AV canal explants in the presence of anti-TGFbeta2 antibody, anti-TGFbeta3 antibody, pertussis toxin, retinoic acid, noggin, or anti-HGF antibody. Only treatment with anti-TGFbeta2 antibody or retinoic acid inhibited Slug expression in AV canal explants. Consistent with these data, we found that retinoic acid disrupted initial steps of EMT, while antagonists of BMP and HGF signaling disrupted later steps of EMT. Transfection of AV canal explants with Slug rescued the inhibitory effect of anti-TGFbeta2 antibody but not retinoic acid on EMT. Slug is thus an essential target of TGFbeta2 signaling during EMT in the developing chicken heart.
Romano
L A
LA
Department of Cell Biology and Anatomy, University of Arizona, Tucson, Arizona 85724, USA.
Runyan
R B
RB
D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D002352:Carrier Proteins; D002642:Chick Embryo; D003094:Collagen / Q000378:metabolism; D046508:Culture Techniques; D004305:Dose-Response Relationship, Drug; D004848:Epithelium / Q000378:metabolism; D006321:Heart / Q000196:embryology*; D017228:Hepatocyte Growth Factor / Q000378:metabolism; D008648:Mesoderm / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D037342:Pertussis Toxin; D010957:Plasmids; D011506:Proteins / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D000071250:Snail Family Transcription Factors; D013997:Time Factors; D014157:Transcription Factors / Q000378:metabolism*; D014158:Transcription, Genetic; D014162:Transfection; D016212:Transforming Growth Factor beta / Q000378:metabolism*; D014212:Tretinoin / Q000494:pharmacology; D010566:Virulence Factors, Bordetella / Q000494:pharmacology; D000099176:Noggin Protein
D019485:Bone Morphogenetic Proteins; D002352:Carrier Proteins; D003094:Collagen; D017228:Hepatocyte Growth Factor; D037342:Pertussis Toxin; D011506:Proteins; D012333:RNA, Messenger; D000071250:Snail Family Transcription Factors; D014157:Transcription Factors; D016212:Transforming Growth Factor beta; D014212:Tretinoin; D010566:Virulence Factors, Bordetella; D000099176:Noggin Protein